BLOG

endpoints

‘Never been more urgent:’ Scynexis looks to tackle superbug crisis with late-stage readout for antifungal hopeful

As the superbug crisis heats up around the world, Scynexis says it has new data from two interim analyses that prove its antifungal has the potential to treat a broad range of infections.